Company intelligence / Profile preview

Aktana

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Aktana is an AI-driven software company focused on optimizing engagement between life sciences companies and healthcare providers, primarily by providing data-driven decision support for commercial, medical, and medtech teams. The company does not develop drugs or therapies itself, but enables pharmaceutical, biotech, and medical device companies to enhance their HCP engagement and marketing strategies, resulting in measurable sales growth and improved commercial outcomes for clients[1][2][3].

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Clients include more than half of the world’s top 20 pharmaceutical companies; supports 350+ brands across over 1,000 deployments[1][3].

Beyond the preview

Go deeper on Aktana.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aktana.

Explore the full profile